AAAAAA
Results:
1-24
|
Results: 24
Authors:
GOLDMAN F
TRIGG M
Citation: F. Goldman et M. Trigg, BONE-MARROW TRANSPLANTATION FOR RELAPSED ACUTE LYMPHOBLASTIC-LEUKEMIA, International journal of pediatric hematology/oncology, 5(2-4), 1998, pp. 215-230
Authors:
KOOK H
GOLDMAN F
GILLER R
GOEKEN N
PETERS C
COMITO M
RUMELHART S
HOLIDA M
LEE N
TRIGG M
Citation: H. Kook et al., RECONSTRUCTION OF THE IMMUNE-SYSTEM AFTER UNRELATED OR PARTIALLY MATCHED T-CELL-DEPLETED BONE-MARROW TRANSPLANTATION IN CHILDREN - FUNCTIONAL ANALYSES OF LYMPHOCYTES AND CORRELATION WITH IMMUNOPHENOTYPIC RECOVERY FOLLOWING TRANSPLANTATION, Clinical and diagnostic laboratory immunology, 4(1), 1997, pp. 96-103
Authors:
UCKUN FM
SATHER H
GAYNON P
ARTHUR D
NACHMAN J
SENSEL M
STEINHERZ P
HUTCHINSON R
TRIGG M
REAMAN G
Citation: Fm. Uckun et al., PROGNOSTIC-SIGNIFICANCE OF THE CD10(-PROGENITOR IMMUNOPHENOTYPE IN CHILDREN WITH ACUTE LYMPHOBLASTIC-LEUKEMIA - A REPORT FROM THE CHILDRENSCANCER GROUP()CD19(+)CD34(+) B), Leukemia & lymphoma, 27(5-6), 1997, pp. 445-457
Authors:
NACHMAN J
SATHER H
LUKENS J
GAYNON P
WOLFF L
CHERLOW J
TRIGG M
Citation: J. Nachman et al., AUGMENTED BERLIN-FRANKFURT-MUNSTER (A-BFM) CHEMOTHERAPY IMPROVES EVENT-FREE SURVIVAL (EFS) FOR CHILDREN WITH ACUTE LYMPHOBLASTIC-LEUKEMIA (ALL) AND UNFAVORABLE PRESENTING FEATURES WHO SHOW A SLOW ENTRY RESPONSE (SER) TO INDUCTION CHEMOTHERAPY, Blood, 90(10), 1997, pp. 2487-2487
Authors:
LANGE B
SATHER H
WEETMAN R
BOSTROM B
MCGUIRE P
RACKOFF W
ARTHUR D
TRIGG M
Citation: B. Lange et al., DOUBLE DELAYED INTENSIFICATION IMPROVES OUTCOME IN MODERATE RISK PEDIATRIC ACUTE LYMPHOBLASTIC-LEUKEMIA (ALL) - A CHILDRENS CANCER GROUP-STUDY, CCG-1891, Blood, 90(10), 1997, pp. 2489-2489
Authors:
UCKUN FM
GAYNON P
SATHER H
ARTHUR D
TRIGG M
TUBERGEN D
NACHMAN J
STEINHERZ P
SENSEL MG
REAMAN GR
Citation: Fm. Uckun et al., CLINICAL-FEATURES AND TREATMENT OUTCOME OF CHILDREN WITH BIPHENOTYPICCD2(-LEUKEMIA - A CHILDRENS CANCER GROUP-STUDY()CD19(+) ACUTE LYMPHOBLASTIC), Blood, 89(7), 1997, pp. 2488-2493
Authors:
UCKUN FM
REAMAN G
STEINHERZ PG
ARTHUR DC
SATHER H
TRIGG M
TUBERGEN D
GAYNON P
Citation: Fm. Uckun et al., IMPROVED CLINICAL OUTCOME FOR CHILDREN WITH T-LINEAGE ACUTE LYMPHOBLASTIC-LEUKEMIA AFTER CONTEMPORARY CHEMOTHERAPY - A CHILDRENS CANCER GROUP-STUDY, Leukemia & lymphoma, 24(1-2), 1996, pp. 57-70
Authors:
STEINHERZ PG
GAYNON P
TRIGG M
SATHER H
BLEYER AW
Citation: Pg. Steinherz et al., CYTOREDUCTION AND PROGNOSIS IN CHILDHOOD ACUTE LYMPHOBLASTIC-LEUKEMIA- IN REPLY, Journal of clinical oncology, 14(8), 1996, pp. 2405-2406
Authors:
SMITH M
ARTHUR D
CAMITTA B
CARROLL AJ
CRIST W
GAYNON P
GELBER R
HEEREMA N
KORN EL
LINK M
MURPHY S
PUI CH
PULLEN J
REAMAN G
SALLAN SE
SATHER H
SHUSTER J
SIMON R
TRIGG M
TUBERGEN D
UCKUN F
UNGERLEIDER R
Citation: M. Smith et al., UNIFORM APPROACH TO RISK CLASSIFICATION AND TREATMENT ASSIGNMENT FOR CHILDREN WITH ACUTE LYMPHOBLASTIC-LEUKEMIA, Journal of clinical oncology, 14(1), 1996, pp. 18-24
Authors:
CHERLOW JM
SATHER H
STEINHERZ P
GAYNON P
TUBERGEN D
TRIGG M
NOVAK L
BLEYER WA
Citation: Jm. Cherlow et al., CRANIOSPINAL IRRADIATION FOR ACUTE LYMPHOBLASTIC-LEUKEMIA WITH CENTRAL-NERVOUS-SYSTEM DISEASE AT DIAGNOSIS - A REPORT FROM THE CHILDRENS CANCER GROUP, International journal of radiation oncology, biology, physics, 36(1), 1996, pp. 19-27
Authors:
RICHARDS S
GRAY R
PETO R
GAYNON P
MASERA G
PESSION A
RONDELLI R
VALSECCHI MG
REITER A
RIEHM H
SCHRAPPE M
MCINTYRE OR
BLEYER A
CAIRO M
REAMAN G
SATHER H
TRIGG M
AUCLERC MF
BANCILLON A
LEPAGE E
SCHAISON G
CLAVELL L
DATTON V
DONNELLY M
GELBER R
SALLAN SE
SACKMANMURIEL F
SANTARELLI MT
PEREZ C
SOLIDORO A
BAILEY C
BURNETT A
CHESSELLS J
EDEN OB
GORDONSMITH EC
LILLEYMAN J
LAND VJ
MAHONEY D
MURPHY S
STEUBER CP
VIETTI T
CRIST W
HANCOCK M
PUI CH
SIMONE J
MITTRA I
SHETTY PA
ALLISON R
BAIGENT C
CLARKE M
DUONG H
DURRANT J
GODWIN J
GREAVES E
HARWOOD C
PETO J
SINCLAIR D
WHEATLEY K
Citation: S. Richards et al., DURATION AND INTENSITY OF MAINTENANCE CHEMOTHERAPY IN ACUTE LYMPHOBLASTIC-LEUKEMIA - OVERVIEW OF 42 TRIALS INVOLVING 12,000 RANDOMIZED CHILDREN, Lancet, 347(9018), 1996, pp. 1783-1788
Authors:
FEIG SA
AMES MM
SATHER HN
STEINHERZ L
REID JM
TRIGG M
PENDERGRASS TW
WARKENTIN P
GERBER M
LEONARD M
BLEYER WA
HARRIS RE
Citation: Sa. Feig et al., COMPARISON OF IDARUBICIN TO DAUNOMYCIN IN A RANDOMIZED MULTIDRUG TREATMENT OF CHILDHOOD ACUTE LYMPHOBLASTIC-LEUKEMIA AT FIRST BONE-MARROW RELAPSE - A REPORT FROM THE CHILDRENS CANCER GROUP, Medical and pediatric oncology, 27(6), 1996, pp. 505-514
Authors:
KOOK H
GOLDMAN F
PADLEY D
GILLER R
RUMELHART S
HOLIDA M
LEE N
PETERS C
COMITO M
HULING D
TRIGG M
Citation: H. Kook et al., RECONSTRUCTION OF THE IMMUNE-SYSTEM AFTER UNRELATED OR PARTIALLY MATCHED T-CELL-DEPLETED BONE-MARROW TRANSPLANTATION IN CHILDREN - IMMUNOPHENOTYPIC ANALYSIS AND FACTORS AFFECTING THE SPEED OF RECOVERY, Blood, 88(3), 1996, pp. 1089-1097
Authors:
UCKUN FM
STEINHERZ PG
SATHER H
TRIGG M
ARTHUR D
TUBERGEN D
GAYNON P
REAMAN G
Citation: Fm. Uckun et al., CD2 ANTIGEN EXPRESSION ON LEUKEMIC-CELLS AS A PREDICTOR OF EVENT-FREESURVIVAL AFTER CHEMOTHERAPY FOR T-LINEAGE ACUTE LYMPHOBLASTIC-LEUKEMIA - A CHILDRENS CANCER GROUP-STUDY, Blood, 88(11), 1996, pp. 4288-4295
Authors:
UCKUN FM
YANG Z
STEINHERZ PG
SATHER H
NACHMAN J
BOSTROM B
REAMAN G
TRIGG M
ARTHUR D
TUBERGEN D
GAYNON P
Citation: Fm. Uckun et al., CELLULAR EXPRESSION OF BCL-2 IN NEWLY-DIAGNOSED CHILDHOOD ACUTE LYMPHOBLASTIC-LEUKEMIA, Blood, 88(10), 1996, pp. 1481-1481
Authors:
UCKUN FM
SATHER H
GAYNON P
ARTHUR D
TRIGG M
TUBERGEN D
NACHMAN J
STEINHERZ P
SENSEL M
REAMAN GR
Citation: Fm. Uckun et al., MYELOID ANTIGEN-POSITIVE CHILDHOOD ACUTE LYMPHOBLASTIC-LEUKEMIA, Blood, 88(10), 1996, pp. 1482-1482
Authors:
GILMAN A
MORRIS C
MOGUL M
MAZUMDER A
LEE CK
GINGRICH R
GOLDMAN F
TRIGG M
Citation: A. Gilman et al., HYDROXYCHLOROQUINE FOR THE TREATMENT OF CHRONIC GRAFT-VERSUS-HOST DISEASE, Blood, 88(10), 1996, pp. 2421-2421
Authors:
UCKUN FM
STEINHERZ PG
SATHER H
TRIGG M
ARTHUR D
TUBERGEN D
GAYNON P
REAMAN G
Citation: Fm. Uckun et al., EFFECT OF CD2 ANTIGEN EXPRESSION ON LEUKEMIC-CELLS ON EVENT-FREE SURVIVAL AFTER CHEMOTHERAPY FOR T-LINEAGE ACUTE LYMPHOBLASTIC-LEUKEMIA, Blood, 88(10), 1996, pp. 2653-2653
Authors:
UCKUN FM
STEINHERZ PG
SATHER H
ARTHUR S
TRIGG M
TUBERGEN D
REAMAN G
GAYNON P
Citation: Fm. Uckun et al., IMPROVED OUTCOME OF CHILDREN WITH T-LINEAGE ACUTE LYMPHOBLASTIC-LEUKEMIA AFTER INTENSIVE CHEMOTHERAPY, Blood, 88(10), 1996, pp. 2656-2656
Authors:
HUTCHINSON RJ
NEERHOUT RC
BERTOLONE S
COOPER HA
ROSKOS R
TANNOUS R
WELLS L
HEEREMA N
HUMMELL D
SAILER S
SATHER H
TRIGG M
Citation: Rj. Hutchinson et al., SHOULD THERAPY BE INTENSIFIED FOR PATIENTS WITH GOOD RISK ALL, Blood, 88(10), 1996, pp. 2662-2662
Authors:
GILLER R
LAUER S
DAHL G
COWAN M
FEUSNER J
BUNIN N
CLOSE P
TRIGG M
GREFFE B
COLORADO U
Citation: R. Giller et al., HIGH-DOSE CHEMOTHERAPY WITH AUTOLOGOUS STEM-CELL RESCUE (HDC ASR) FORREFRACTORY GERM-CELL CANCER (GCC) IN CHILDREN/, Experimental hematology, 23(8), 1995, pp. 855-855
Authors:
NACHMAN J
SATHER H
LUKENS J
GAYNON P
WOLFF L
ARTHUR D
CHERLOW J
TRIGG M
SMITH S
Citation: J. Nachman et al., NERVOUS-SYSTEM (CNS) PROPHYLAXIS FOR HIGH-RISK PATIENTS WITH ACUTE LYMPHOBLASTIC-LEUKEMIA (ALL) SHOWING A RAPID EARLY RESPONSE (RER) TO BFMINDUCTION CHEMOTHERAPY, Blood, 86(10), 1995, pp. 1047-1047
Authors:
LANGE B
SATHER H
WEETMAN R
CHERLOW J
MCGUIRECULLEN P
ARTHUR D
WIMMER R
ROSENFIELD N
TRIGG M
RACKOFF W
BOSTROM B
Citation: B. Lange et al., PREDICTIVE VALUE OF EARLY RESPONSE IN INTERMEDIATE RISK ACUTE LYMPHOBLASTIC-LEUKEMIA IN CHILDREN, CHILDRENS CANCER GROUP (CCG) 1891, Blood, 86(10), 1995, pp. 3054-3054
Authors:
UCKUN FM
SATHER H
REAMAN G
SHUSTER J
LAND V
TRIGG M
GUNTHER R
CHELSTROM L
BLEYER A
GAYNON P
CRIST W
Citation: Fm. Uckun et al., LEUKEMIC-CELL GROWTH IN SCID MICE AS A PREDICTOR OF RELAPSE IN HIGH-RISK B-LINEAGE ACUTE LYMPHOBLASTIC-LEUKEMIA, Blood, 85(4), 1995, pp. 873-878
Risultati:
1-24
|